Kursprognose für Apnimed Inc (APMD)APMDApnimed Inc

Alphio's APMD stock price prediction model matches the current Apnimed Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $19.25 (+1.37%). The 1-week path is $18.55 (-2.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Apnimed is a good buy right now due to its strong financial turnaround, highlighted by a net income of $125.93 million in Q2 2026, and a remarkable gross margin of 89.98%. The stock has shown a positive trend with a 5-day change of +6.93% and is currently trading at $18.99, well below analyst price targets, indicating significant upside potential. However, the main risk is the upcoming FDA decision on February 28, 2027, which could impact the stock's performance.

Apnimed Inc (APMD) last closed at $18.99, gaining +2.48%. These facts feed the 1-day and 1-week APMD price prediction above.